C-telopeptide (CTX) is an important biomarker used to measure bone resorption, the natural breakdown and recycling of bone tissue. When bone is broken down, fragments of type I collagen—including CTX—are released into the bloodstream, making this test valuable for evaluating bone turnover, osteoporosis risk, menopausal bone loss, metabolic bone disorders, and treatment response. The typical reference range for CTX is 50–465 pg/mL, although optimal values can vary based on age, sex, fasting status, and hormonal stage. Higher CTX levels may indicate increased bone breakdown, which can occur with menopause-related bone loss, vitamin D deficiency, hyperparathyroidism, chronic inflammation, steroid use, prolonged immobilization, or certain endocrine disorders. Persistently elevated CTX levels may reflect accelerated bone loss and a higher long-term fracture risk. Lower CTX levels generally indicate slower bone turnover and may represent healthy bone balance or a positive response to osteoporosis therapies such as bisphosphonates or hormone-based treatment. Because CTX can vary throughout the day and is influenced by fasting, medication timing, and physical activity, testing is most accurate when performed in the morning and under consistent conditions. CTX results provide the most value when interpreted alongside other bone-related markers—including P1NP, calcium, vitamin D, and parathyroid hormone (PTH)—and imaging studies like bone density scans, helping guide treatment decisions and long-term bone health management.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.